BOOK
Sports Cardiology, An Issue of Cardiology Clinics, E-Book
Aaron Baggish | Andre La Gerche
(2016)
Additional Information
Book Details
Abstract
This issue of Cardiology Clinics on Sports Cardiology, edited by Drs. Aaron Baggish and Andre La Gerche, will cover a variety of aspects related to cardiovascular health and complications related to athletic activity. Topics covered in this issue include, but are not limited to, molecular aspects of exercise-induced cardiac remodeling; sudden cardiac death; atrial fibrillation in endurance athletes; congenital heart disease in athletes; exercise prescription for the athlete with cardiomyopathy; and advanced exercise testing for the sports cardiologist.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Sports Cardiology | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| EDITORIAL BOARD | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: Sports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals\r | vii | ||
| A Modern Definition of the Athlete’s Heart—for Research and the Clinic\r | vii | ||
| Molecular Aspects of Exercise-induced Cardiac Remodeling\r | vii | ||
| Sudden Cardiac Death in Athletes: Still Much to Learn\r | vii | ||
| Using the 12-Lead Electrocardiogram in the Care of Athletic Patients\r | viii | ||
| Exercise-Induced Atrial Remodeling: The Forgotten Chamber\r | viii | ||
| Atrial Fibrillation in Endurance Athletes: From Mechanism to Management\r | viii | ||
| Congenital Heart Disease and the Athlete: What We Know and What We Do Not Know\r | viii | ||
| Exercise Prescription for the Athlete with Cardiomyopathy\r | ix | ||
| Beyond the Bruce Protocol: Advanced Exercise Testing for the Sports Cardiologist\r | ix | ||
| Special Articles | ix | ||
| Quick Evidence Synopsis: Coronary Artery Revascularization in Patients with Acute Coronary Syndrome and Comorbid Renal Dise \r | ix | ||
| Quick Evidence Synopsis: Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting for Patients with Coronary A ... | ix | ||
| CARDIOLOGY CLINICS\r | x | ||
| FORTHCOMING ISSUES | x | ||
| February 2017 | x | ||
| May 2017 | x | ||
| August 2017 | x | ||
| RECENT ISSUES | x | ||
| August 2016 | x | ||
| May 2016 | x | ||
| February 2016 | x | ||
| Preface:\rSports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals | xi | ||
| A Modern Definition of the Athlete’s Heart—for Research and the Clinic | 507 | ||
| Key points | 507 | ||
| INTRODUCTION | 507 | ||
| WHAT DETERMINES CARDIAC REMODELING? | 508 | ||
| CRITIQUE OF THE MITCHELL CLASSIFICATION | 509 | ||
| CAN WE DO BETTER? | 511 | ||
| RESEARCH AND THE CLINICAL IMPLICATIONS | 511 | ||
| SUMMARY | 512 | ||
| REFERENCES | 513 | ||
| Molecular Aspects of Exercise-induced Cardiac Remodeling | 515 | ||
| Key points | 515 | ||
| INTRODUCTION | 515 | ||
| MOLECULAR MECHANISMS ASSOCIATED WITH ADAPTIVE EXERCISE-INDUCED CARDIAC REMODELING | 516 | ||
| Cardiac Myocyte Hypertrophy and Renewal/Proliferation | 517 | ||
| Studies specifically assessing cardiac myocyte renewal/proliferation | 518 | ||
| Cardiac Myocyte Contractility and Sarcomeric Remodeling | 519 | ||
| Extracellular Matrix Remodeling | 521 | ||
| Cell Survival | 521 | ||
| Metabolic and Mitochondrial Adaptations | 521 | ||
| Electrical Remodeling | 521 | ||
| Angiogenesis and Vascular Remodeling | 522 | ||
| Emerging Role of microRNAs in Exercise-induced Cardiac Remodeling | 522 | ||
| Other Factors Affecting Exercise-induced Cardiac Remodeling | 523 | ||
| MOLECULAR MECHANISMS ASSOCIATED WITH MALADAPTIVE EXERCISE-INDUCED CARDIAC REMODELING | 523 | ||
| THERAPEUTIC APPROACHES THAT TARGET KEY MECHANISMS RESPONSIBLE FOR EXERCISE-INDUCED ADAPTIVE CARDIAC REMODELING | 523 | ||
| Gene Therapy | 524 | ||
| MicroRNA-based Treatments | 524 | ||
| Small Molecules That Activate the Insulin-like Growth Factor 1–Phosphoinositide 3-Kinase–-Protein Kinase B Signaling Cascade | 525 | ||
| Small molecule–activating insulin-like growth factor 1 receptor | 525 | ||
| Small molecule–activating protein kinase B | 525 | ||
| SUMMARY | 525 | ||
| REFERENCES | 525 | ||
| Sudden Cardiac Death in Athletes | 531 | ||
| Key points | 531 | ||
| INTRODUCTION | 531 | ||
| INCIDENCE OF SUDDEN CARDIAC DEATH IN ATHLETES | 532 | ||
| CAUSES OF SUDDEN CARDIAC DEATH IN ATHLETES | 532 | ||
| Inherited Structural Diseases | 534 | ||
| Hypertrophic cardiomyopathy | 534 | ||
| Arrhythmogenic right ventricular cardiomyopathy/dysplasia | 534 | ||
| Inherited Arrhythmia Disorders | 534 | ||
| Long QT syndrome | 534 | ||
| Catecholaminergic polymorphic ventricular tachycardia | 534 | ||
| Acquired Causes of Sudden Cardiac Death | 535 | ||
| WHEN TRAGEDY STRIKES: FOLLOWING THE SUDDEN CARDIAC DEATH OF AN ATHLETE | 535 | ||
| Comprehensive Postmortem Examination | 535 | ||
| Clinical Screening of the Family | 536 | ||
| Role of the Molecular Autopsy | 537 | ||
| STILL MUCH TO LEARN | 537 | ||
| SUMMARY | 538 | ||
| REFERENCES | 539 | ||
| Using the 12-Lead Electrocardiogram in the Care of Athletic Patients | 543 | ||
| Key points | 543 | ||
| INTRODUCTION | 543 | ||
| DEFINITION OF AN ATHLETE | 543 | ||
| ORIGINS OF THE ATHLETE’S HEART | 544 | ||
| THE ATHLETE’S ELECTROCARDIOGRAM | 544 | ||
| DETERMINANTS OF ELECTROCARDIOGRAM PATTERNS IN ATHLETES | 544 | ||
| Age | 545 | ||
| Gender | 546 | ||
| Ethnicity | 546 | ||
| TYPE AND INTENSITY OF SPORT | 546 | ||
| SUDDEN CARDIAC DEATH IN ATHLETES | 547 | ||
| THE ELECTROCARDIOGRAM'S ROLE IN DIAGNOSIS, PROGNOSIS, AND RISK STRATIFICATION OF POTENTIALLY SERIOUS CARDIOVASCULAR ABNORMA ... | 547 | ||
| THE EVOLUTION OF ELECTROCARDIOGRAM INTERPRETATION IN ATHLETES | 548 | ||
| THE EUROPEAN SOCIETY OF CARDIOLOGY CRITERIA | 549 | ||
| THE SEATTLE CRITERIA | 549 | ||
| THE REFINED CRITERIA | 550 | ||
| FUTURE PROGRESS | 550 | ||
| DOES ELECTROCARDIOGRAM SCREENING SAVE LIVES? | 551 | ||
| LIMITATIONS OF THE ELECTROCARDIOGRAM | 553 | ||
| Variation in Interpretation | 553 | ||
| Cardiac Conditions Undetectable by Electrocardiogram | 553 | ||
| MASTERS ATHLETES | 553 | ||
| SUMMARY | 553 | ||
| REFERENCES | 553 | ||
| Exercise-Induced Atrial Remodeling | 557 | ||
| Key points | 557 | ||
| BACKGROUND | 557 | ||
| ECHOCARDIOGRAPHY ATRIAL ABNORMALITIES IN ATHLETES | 558 | ||
| LEFT ATRIAL ECHOCARDIOGRAPHIC EVALUATION: FROM STANDARD MEASUREMENTS TO NEW ECHO TECHNOLOGIES | 558 | ||
| LEFT ATRIAL DIAMETER IN ATHLETES | 560 | ||
| LEFT ATRIAL VOLUME INDEX IN ATHLETES | 560 | ||
| LEFT ATRIAL MYOCARDIAL FUNCTION IN ATHLETES | 561 | ||
| CLINICAL IMPACT: ATRIAL FIBRILLATION IN ATHLETES | 561 | ||
| CARDIAC MAGNETIC RESONANCE AND LEFT ATRIAL MORPHOLOGY IN ATHLETES | 563 | ||
| SUMMARY | 563 | ||
| REFERENCES | 564 | ||
| Atrial Fibrillation in Endurance Athletes | 567 | ||
| Key points | 567 | ||
| INTRODUCTION | 567 | ||
| PREVALENCE OF ATRIAL ARRHYTHMIAS IN ENDURANCE ATHLETES | 568 | ||
| Searching for a Common Definition | 568 | ||
| MECHANISMS IN THE PATHOGENESIS OF ATRIAL FIBRILLATION IN ATHLETES | 569 | ||
| Atrial Structural Remodeling | 569 | ||
| Autonomic Influences | 570 | ||
| Atrial Ectopic Triggers | 570 | ||
| MANAGEMENT OF ATRIAL FIBRILLATION IN ATHLETES | 571 | ||
| Evaluation of an Athlete with Atrial Fibrillation | 571 | ||
| Detraining | 571 | ||
| Rate Control | 571 | ||
| Rhythm Control | 573 | ||
| Anticoagulation | 574 | ||
| FUTURE DIRECTIONS | 575 | ||
| SUMMARY | 575 | ||
| REFERENCES | 576 | ||
| Congenital Heart Disease and the Athlete | 579 | ||
| Key points | 579 | ||
| CASE EXAMPLES | 579 | ||
| INTRODUCTION | 580 | ||
| THE CASE FOR PARTICIPATION | 580 | ||
| RESTRICTING PATIENTS SHOULD NOT BE TAKEN LIGHTLY (AND ONLY DONE WHEN THERE IS EVIDENCE TO RESTRICT AND NOT THE OTHER WAY AR ... | 580 | ||
| THE CASE FOR RESTRICTION | 580 | ||
| WHAT IS KNOWN ABOUT THE SUBJECT | 584 | ||
| Risk of Sudden Death in Patients with Congenital Heart Disease | 584 | ||
| Physiologic Changes with Exercise | 584 | ||
| Exercise Training and Sports Improve Short-term Fitness Measurements | 584 | ||
| Physicians Do Not Universally Follow the Congenital Heart Disease Sports Participation Guidelines | 584 | ||
| If Sudden Cardiac Arrest Occurs, the Athlete May Be Safer at a Training Facility or Sporting Event Instead of an Unsupervis ... | 585 | ||
| WHAT IS NOT KNOWN ABOUT THE SUBJECT | 585 | ||
| The Risk of Sudden Death with Exercise in Each Patient with Congenital Heart Disease | 585 | ||
| Long-term Physiologic Changes Due to Exercise | 585 | ||
| Can You Positively Motivate Somebody to Participate in Sports or to Exercise? | 585 | ||
| RETURNING TO THE CASE EXAMPLES | 585 | ||
| SUMMARY | 586 | ||
| REFERENCES | 586 | ||
| Exercise Prescription for the Athlete with Cardiomyopathy | 591 | ||
| Key points | 591 | ||
| INHERITED CARDIOMYOPATHIES PRIMER | 591 | ||
| Hypertrophic Cardiomyopathy | 591 | ||
| Dilated Cardiomyopathy | 592 | ||
| Left Ventricle Noncompaction | 592 | ||
| Arrhythmogenic Right Ventricular Cardiomyopathy | 593 | ||
| INCIDENCE OF SUDDEN CARDIAC DEATH IN ATHLETES | 593 | ||
| RISK AND CAUSE OF SUDDEN CARDIAC DEATH IN ATHLETES WITH CARDIOMYOPATHY | 594 | ||
| GUIDELINES: BETHESDA AND BEYOND | 596 | ||
| APPROACH TO THE ATHLETE WITH CARDIOMYOPATHY | 597 | ||
| SUMMARY | 598 | ||
| REFERENCES | 599 | ||
| Beyond the Bruce Protocol | 603 | ||
| Key points | 603 | ||
| INTRODUCTION | 603 | ||
| GRADED EXERCISE TESTING | 604 | ||
| NONGRADED EXERCISE TESTING | 604 | ||
| REMOTE EXERCISE MONITORING | 606 | ||
| CASE STUDY | 606 | ||
| SUMMARY | 607 | ||
| SUPPLEMENTARY DATA | 607 | ||
| REFERENCES | 607 | ||
| Quick Evidence Synopsis | 609 | ||
| AUTHOR COMMENTARY | 612 | ||
| GLOSSARY | 613 | ||
| RECOMMENDED CITATION | 613 | ||
| DISCLAIMER | 613 | ||
| REFERENCES | 613 | ||
| Quick Evidence Synopsis | 615 | ||
| AUTHOR COMMENTARY | 619 | ||
| GLOSSARY | 619 | ||
| RECOMMENDED CITATION | 619 | ||
| DISCLAIMER | 619 | ||
| REFERENCES | 620 | ||
| Index | 623 |